LMP 2390: Innovating Medicine, Health and Care

Type: Module

Credit: 0.25 FCE

Overview

This is a module and counts as 0.25 FCE. This course is offered Winter 2024; Tues 3 – 5 pm; Feb 23 – Apr 6

Learning outcomes

At the end of this module students will be able to: 

  • Demonstrate an understanding of key topics in health innovation
  • Apply the Translational Framework for collaborative rapid innovation,  critically analyze a problem
  • Demonstrate a conceptual intervention

Description

The Toronto Translational Framework provides an overview of the journey from ideation to implementation of innovations–from concept generation to market diffusion.  This module blends a rapid innovation challenge with learning key definitions, regulations and jurisdictional topics along commercialization pathways. The instructional content provides a high-level overview of innovation pathways for devices, services, diagnostics and therapeutics primarily in Canada, US and EU, with active ideation and creative problem-solving.

Enrollment

Students are required to complete eight modules (0.25 FCE each) spread out within 2 years of study. Students may enroll in modular courses using ACORN. The modular schedule will be emailed to students prior to the start of each semester. Modules offered outside of the program are also permitted such as ones offered by the Institute of Medical Science (IMS).
 

Teaching team

Paul Chipperton

A 25-year veteran of life science start-ups, currently as CEO & President of Insight Medbotics Inc. Formerly as co-founder & CEO of an award-winning Prostate Cancer MedDev. company established in Toronto, Profound Medical Inc. (NASDAQ:PROF). Paul has recently migrated into a blend of running companies in the day, and in the evenings and weekends lecturing on the topics of strategic innovation, venture capital finance, and marketing consulting to Federal and Provincial bodies; whilst continuing his advisory and investment activities on multiple boards.